2,071 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Purchased by Petros Family Wealth LLC

Petros Family Wealth LLC purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund purchased 2,071 shares of the medical equipment provider’s stock, valued at approximately $1,081,000. Intuitive Surgical comprises 1.2% of Petros Family Wealth LLC’s investment portfolio, making the stock its 21st largest position.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Sterling Capital Management LLC lifted its position in shares of Intuitive Surgical by 4.4% during the fourth quarter. Sterling Capital Management LLC now owns 18,577 shares of the medical equipment provider’s stock valued at $9,696,000 after purchasing an additional 790 shares in the last quarter. Concorde Asset Management LLC lifted its position in shares of Intuitive Surgical by 21.2% during the 4th quarter. Concorde Asset Management LLC now owns 554 shares of the medical equipment provider’s stock worth $289,000 after buying an additional 97 shares in the last quarter. Coign Capital Advisors LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $651,000. Heritage Trust Co bought a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $917,000. Finally, Oak Associates Ltd. OH increased its position in shares of Intuitive Surgical by 2.9% during the fourth quarter. Oak Associates Ltd. OH now owns 11,023 shares of the medical equipment provider’s stock valued at $5,754,000 after acquiring an additional 313 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Shares of ISRG opened at $493.60 on Friday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The company has a market capitalization of $175.81 billion, a P/E ratio of 77.00, a P/E/G ratio of 5.85 and a beta of 1.55. The firm’s 50 day simple moving average is $532.72 and its 200 day simple moving average is $532.36.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on ISRG shares. JPMorgan Chase & Co. boosted their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Raymond James boosted their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Piper Sandler restated an “overweight” rating and set a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. UBS Group increased their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. Finally, Robert W. Baird lowered their price target on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a report on Tuesday, March 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $611.86.

Insider Activity

In related news, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 33,754 shares of company stock worth $17,691,621. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.